nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—ADRB1—stomach cancer	0.424	0.543	CbGaD
Bisoprolol—ADRB2—stomach cancer	0.357	0.457	CbGaD
Bisoprolol—Practolol—ADRB1—stomach cancer	0.00067	0.0794	CrCbGaD
Bisoprolol—Esmolol—ADRB1—stomach cancer	0.000481	0.057	CrCbGaD
Bisoprolol—Bevantolol—ADRB1—stomach cancer	0.000476	0.0563	CrCbGaD
Bisoprolol—Betaxolol—ADRB1—stomach cancer	0.000424	0.0502	CrCbGaD
Bisoprolol—Atenolol—ADRB1—stomach cancer	0.00042	0.0497	CrCbGaD
Bisoprolol—Esmolol—ADRB2—stomach cancer	0.000405	0.0479	CrCbGaD
Bisoprolol—Bevantolol—ADRB2—stomach cancer	0.0004	0.0474	CrCbGaD
Bisoprolol—Acebutolol—ADRB1—stomach cancer	0.000388	0.0459	CrCbGaD
Bisoprolol—Oxprenolol—ADRB1—stomach cancer	0.000385	0.0456	CrCbGaD
Bisoprolol—Betaxolol—ADRB2—stomach cancer	0.000356	0.0422	CrCbGaD
Bisoprolol—Atenolol—ADRB2—stomach cancer	0.000353	0.0418	CrCbGaD
Bisoprolol—Alprenolol—ADRB1—stomach cancer	0.000352	0.0417	CrCbGaD
Bisoprolol—Metoprolol—ADRB1—stomach cancer	0.000327	0.0388	CrCbGaD
Bisoprolol—Acebutolol—ADRB2—stomach cancer	0.000326	0.0386	CrCbGaD
Bisoprolol—Oxprenolol—ADRB2—stomach cancer	0.000324	0.0383	CrCbGaD
Bisoprolol—Alprenolol—HTR1A—stomach cancer	0.000315	0.0373	CrCbGaD
Bisoprolol—Pindolol—ADRB1—stomach cancer	0.000303	0.0359	CrCbGaD
Bisoprolol—Alprenolol—ADRB2—stomach cancer	0.000296	0.0351	CrCbGaD
Bisoprolol—Metoprolol—ADRB2—stomach cancer	0.000275	0.0326	CrCbGaD
Bisoprolol—Pindolol—HTR1A—stomach cancer	0.000271	0.0321	CrCbGaD
Bisoprolol—Pindolol—ADRB2—stomach cancer	0.000255	0.0302	CrCbGaD
Bisoprolol—Chlorphenesin—PTGS2—stomach cancer	0.000189	0.0224	CrCbGaD
Bisoprolol—Propranolol—ADRB1—stomach cancer	0.000165	0.0196	CrCbGaD
Bisoprolol—Propranolol—HTR1A—stomach cancer	0.000148	0.0175	CrCbGaD
Bisoprolol—Propranolol—ADRB2—stomach cancer	0.000139	0.0165	CrCbGaD
Bisoprolol—Sweating—Doxorubicin—stomach cancer	0.000125	0.000608	CcSEcCtD
Bisoprolol—Hyperhidrosis—Capecitabine—stomach cancer	0.000125	0.000606	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—stomach cancer	0.000125	0.000606	CcSEcCtD
Bisoprolol—Hypotension—Docetaxel—stomach cancer	0.000125	0.000605	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—stomach cancer	0.000124	0.000605	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000123	0.0006	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—stomach cancer	0.000123	0.000596	CcSEcCtD
Bisoprolol—Vomiting—Irinotecan—stomach cancer	0.000123	0.000596	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—stomach cancer	0.000122	0.000595	CcSEcCtD
Bisoprolol—Dizziness—Fluorouracil—stomach cancer	0.000122	0.000594	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—stomach cancer	0.000122	0.000593	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—stomach cancer	0.000122	0.000592	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—stomach cancer	0.000122	0.000592	CcSEcCtD
Bisoprolol—Rash—Irinotecan—stomach cancer	0.000122	0.000591	CcSEcCtD
Bisoprolol—Dermatitis—Irinotecan—stomach cancer	0.000121	0.00059	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000121	0.00059	CcSEcCtD
Bisoprolol—Headache—Irinotecan—stomach cancer	0.000121	0.000587	CcSEcCtD
Bisoprolol—Hypotension—Capecitabine—stomach cancer	0.000121	0.000586	CcSEcCtD
Bisoprolol—Insomnia—Docetaxel—stomach cancer	0.000121	0.000586	CcSEcCtD
Bisoprolol—Paraesthesia—Docetaxel—stomach cancer	0.00012	0.000582	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—stomach cancer	0.000119	0.000581	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—stomach cancer	0.000119	0.000579	CcSEcCtD
Bisoprolol—Dyspnoea—Docetaxel—stomach cancer	0.000119	0.000578	CcSEcCtD
Bisoprolol—Somnolence—Docetaxel—stomach cancer	0.000119	0.000576	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—stomach cancer	0.000118	0.000576	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—stomach cancer	0.000118	0.000575	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—stomach cancer	0.000118	0.000574	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—stomach cancer	0.000118	0.000572	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000118	0.000572	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—stomach cancer	0.000117	0.000571	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—stomach cancer	0.000117	0.000571	CcSEcCtD
Bisoprolol—Vomiting—Fluorouracil—stomach cancer	0.000117	0.000571	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—stomach cancer	0.000117	0.000571	CcSEcCtD
Bisoprolol—Dyspepsia—Docetaxel—stomach cancer	0.000117	0.00057	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—stomach cancer	0.000117	0.000569	CcSEcCtD
Bisoprolol—Insomnia—Capecitabine—stomach cancer	0.000117	0.000567	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—stomach cancer	0.000117	0.000566	CcSEcCtD
Bisoprolol—Rash—Fluorouracil—stomach cancer	0.000116	0.000566	CcSEcCtD
Bisoprolol—Dermatitis—Fluorouracil—stomach cancer	0.000116	0.000566	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—stomach cancer	0.000116	0.000565	CcSEcCtD
Bisoprolol—Paraesthesia—Capecitabine—stomach cancer	0.000116	0.000563	CcSEcCtD
Bisoprolol—Headache—Fluorouracil—stomach cancer	0.000116	0.000562	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—stomach cancer	0.000115	0.000561	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—stomach cancer	0.000115	0.00056	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000115	0.000559	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000115	0.000559	CcSEcCtD
Bisoprolol—Dyspnoea—Capecitabine—stomach cancer	0.000115	0.000559	CcSEcCtD
Bisoprolol—Fatigue—Docetaxel—stomach cancer	0.000115	0.000559	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—stomach cancer	0.000115	0.000558	CcSEcCtD
Bisoprolol—Nausea—Irinotecan—stomach cancer	0.000115	0.000557	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—stomach cancer	0.000114	0.000554	CcSEcCtD
Bisoprolol—Pain—Docetaxel—stomach cancer	0.000114	0.000554	CcSEcCtD
Bisoprolol—Constipation—Docetaxel—stomach cancer	0.000114	0.000554	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—stomach cancer	0.000114	0.000554	CcSEcCtD
Bisoprolol—Dyspepsia—Capecitabine—stomach cancer	0.000114	0.000552	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—stomach cancer	0.000113	0.00055	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—stomach cancer	0.000113	0.000549	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—stomach cancer	0.000112	0.000544	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000111	0.000542	CcSEcCtD
Bisoprolol—Fatigue—Capecitabine—stomach cancer	0.000111	0.000541	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—stomach cancer	0.000111	0.000539	CcSEcCtD
Bisoprolol—Pain—Capecitabine—stomach cancer	0.00011	0.000536	CcSEcCtD
Bisoprolol—Constipation—Capecitabine—stomach cancer	0.00011	0.000536	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—stomach cancer	0.00011	0.000536	CcSEcCtD
Bisoprolol—Feeling abnormal—Docetaxel—stomach cancer	0.00011	0.000534	CcSEcCtD
Bisoprolol—Nausea—Fluorouracil—stomach cancer	0.00011	0.000533	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—stomach cancer	0.000109	0.000532	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—stomach cancer	0.000109	0.000531	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—stomach cancer	0.000109	0.000531	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000109	0.00053	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—stomach cancer	0.000109	0.000528	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—stomach cancer	0.000109	0.000528	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—stomach cancer	0.000108	0.000524	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—stomach cancer	0.000107	0.000518	CcSEcCtD
Bisoprolol—Feeling abnormal—Capecitabine—stomach cancer	0.000106	0.000517	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—stomach cancer	0.000106	0.000516	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—stomach cancer	0.000106	0.000516	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—stomach cancer	0.000106	0.000515	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—stomach cancer	0.000106	0.000514	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000106	0.000513	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000106	0.000513	CcSEcCtD
Bisoprolol—Abdominal pain—Docetaxel—stomach cancer	0.000105	0.000512	CcSEcCtD
Bisoprolol—Body temperature increased—Docetaxel—stomach cancer	0.000105	0.000512	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—stomach cancer	0.000105	0.000508	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—stomach cancer	0.000103	0.000503	CcSEcCtD
Bisoprolol—Cough—Methotrexate—stomach cancer	0.000103	0.000499	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—stomach cancer	0.000103	0.000499	CcSEcCtD
Bisoprolol—Urticaria—Capecitabine—stomach cancer	0.000103	0.000498	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—stomach cancer	0.000102	0.000497	CcSEcCtD
Bisoprolol—Abdominal pain—Capecitabine—stomach cancer	0.000102	0.000496	CcSEcCtD
Bisoprolol—Body temperature increased—Capecitabine—stomach cancer	0.000102	0.000496	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—stomach cancer	0.000102	0.000496	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—stomach cancer	0.000101	0.000492	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—stomach cancer	0.0001	0.000487	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—stomach cancer	0.0001	0.000487	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—stomach cancer	0.0001	0.000487	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—stomach cancer	9.98e-05	0.000485	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	9.95e-05	0.000484	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—stomach cancer	9.93e-05	0.000483	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—stomach cancer	9.9e-05	0.000481	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—stomach cancer	9.9e-05	0.000481	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—stomach cancer	9.88e-05	0.00048	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—stomach cancer	9.86e-05	0.000479	CcSEcCtD
Bisoprolol—Hypersensitivity—Docetaxel—stomach cancer	9.82e-05	0.000477	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—stomach cancer	9.8e-05	0.000476	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—stomach cancer	9.74e-05	0.000473	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—stomach cancer	9.69e-05	0.000471	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—stomach cancer	9.68e-05	0.000471	CcSEcCtD
Bisoprolol—Cough—Epirubicin—stomach cancer	9.61e-05	0.000467	CcSEcCtD
Bisoprolol—Asthenia—Docetaxel—stomach cancer	9.56e-05	0.000465	CcSEcCtD
Bisoprolol—Infection—Methotrexate—stomach cancer	9.54e-05	0.000464	CcSEcCtD
Bisoprolol—Hypersensitivity—Capecitabine—stomach cancer	9.51e-05	0.000462	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—stomach cancer	9.46e-05	0.00046	CcSEcCtD
Bisoprolol—Pruritus—Docetaxel—stomach cancer	9.43e-05	0.000458	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—stomach cancer	9.42e-05	0.000458	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—stomach cancer	9.41e-05	0.000457	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—stomach cancer	9.38e-05	0.000456	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—stomach cancer	9.38e-05	0.000456	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—stomach cancer	9.38e-05	0.000456	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—stomach cancer	9.37e-05	0.000455	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—stomach cancer	9.35e-05	0.000454	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—stomach cancer	9.33e-05	0.000454	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	9.31e-05	0.000453	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—stomach cancer	9.29e-05	0.000451	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—stomach cancer	9.27e-05	0.00045	CcSEcCtD
Bisoprolol—Asthenia—Capecitabine—stomach cancer	9.26e-05	0.00045	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—stomach cancer	9.19e-05	0.000447	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—stomach cancer	9.17e-05	0.000446	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—stomach cancer	9.16e-05	0.000445	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—stomach cancer	9.14e-05	0.000444	CcSEcCtD
Bisoprolol—Pruritus—Capecitabine—stomach cancer	9.13e-05	0.000444	CcSEcCtD
Bisoprolol—Diarrhoea—Docetaxel—stomach cancer	9.12e-05	0.000443	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—stomach cancer	9.07e-05	0.000441	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—stomach cancer	9.01e-05	0.000438	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—stomach cancer	8.99e-05	0.000437	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—stomach cancer	8.98e-05	0.000436	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—stomach cancer	8.96e-05	0.000436	CcSEcCtD
Bisoprolol—Infection—Epirubicin—stomach cancer	8.93e-05	0.000434	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—stomach cancer	8.89e-05	0.000432	CcSEcCtD
Bisoprolol—Shock—Epirubicin—stomach cancer	8.85e-05	0.00043	CcSEcCtD
Bisoprolol—Diarrhoea—Capecitabine—stomach cancer	8.83e-05	0.000429	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—stomach cancer	8.82e-05	0.000429	CcSEcCtD
Bisoprolol—Dizziness—Docetaxel—stomach cancer	8.81e-05	0.000428	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—stomach cancer	8.8e-05	0.000428	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—stomach cancer	8.78e-05	0.000427	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.75e-05	0.000425	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—stomach cancer	8.73e-05	0.000425	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—stomach cancer	8.69e-05	0.000423	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—stomach cancer	8.69e-05	0.000422	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—stomach cancer	8.68e-05	0.000422	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—stomach cancer	8.68e-05	0.000422	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—stomach cancer	8.68e-05	0.000422	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—stomach cancer	8.65e-05	0.00042	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—stomach cancer	8.63e-05	0.000419	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	8.62e-05	0.000419	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—stomach cancer	8.57e-05	0.000417	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—stomach cancer	8.57e-05	0.000416	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—stomach cancer	8.54e-05	0.000415	CcSEcCtD
Bisoprolol—Dizziness—Capecitabine—stomach cancer	8.53e-05	0.000415	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—stomach cancer	8.49e-05	0.000413	CcSEcCtD
Bisoprolol—Vomiting—Docetaxel—stomach cancer	8.48e-05	0.000412	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—stomach cancer	8.46e-05	0.000411	CcSEcCtD
Bisoprolol—Rash—Docetaxel—stomach cancer	8.4e-05	0.000409	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—stomach cancer	8.4e-05	0.000408	CcSEcCtD
Bisoprolol—Dermatitis—Docetaxel—stomach cancer	8.4e-05	0.000408	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—stomach cancer	8.39e-05	0.000408	CcSEcCtD
Bisoprolol—Headache—Docetaxel—stomach cancer	8.35e-05	0.000406	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—stomach cancer	8.32e-05	0.000404	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—stomach cancer	8.29e-05	0.000403	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—stomach cancer	8.28e-05	0.000403	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—stomach cancer	8.26e-05	0.000402	CcSEcCtD
Bisoprolol—Pain—Methotrexate—stomach cancer	8.22e-05	0.000399	CcSEcCtD
Bisoprolol—Vomiting—Capecitabine—stomach cancer	8.21e-05	0.000399	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	8.19e-05	0.000398	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—stomach cancer	8.18e-05	0.000398	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—stomach cancer	8.16e-05	0.000397	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—stomach cancer	8.15e-05	0.000396	CcSEcCtD
Bisoprolol—Rash—Capecitabine—stomach cancer	8.14e-05	0.000396	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—stomach cancer	8.13e-05	0.000395	CcSEcCtD
Bisoprolol—Dermatitis—Capecitabine—stomach cancer	8.13e-05	0.000395	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—stomach cancer	8.12e-05	0.000395	CcSEcCtD
Bisoprolol—Headache—Capecitabine—stomach cancer	8.09e-05	0.000393	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—stomach cancer	8.08e-05	0.000393	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—stomach cancer	8.07e-05	0.000392	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—stomach cancer	8.04e-05	0.000391	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—stomach cancer	8.02e-05	0.00039	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—stomach cancer	7.99e-05	0.000389	CcSEcCtD
Bisoprolol—Nausea—Docetaxel—stomach cancer	7.92e-05	0.000385	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—stomach cancer	7.92e-05	0.000385	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—stomach cancer	7.91e-05	0.000385	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—stomach cancer	7.86e-05	0.000382	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—stomach cancer	7.77e-05	0.000378	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—stomach cancer	7.76e-05	0.000377	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—stomach cancer	7.75e-05	0.000377	CcSEcCtD
Bisoprolol—Pain—Epirubicin—stomach cancer	7.69e-05	0.000374	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—stomach cancer	7.69e-05	0.000374	CcSEcCtD
Bisoprolol—Nausea—Capecitabine—stomach cancer	7.67e-05	0.000373	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—stomach cancer	7.63e-05	0.000371	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—stomach cancer	7.59e-05	0.000369	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—stomach cancer	7.59e-05	0.000369	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.58e-05	0.000368	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—stomach cancer	7.52e-05	0.000366	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—stomach cancer	7.47e-05	0.000363	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—stomach cancer	7.42e-05	0.000361	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—stomach cancer	7.41e-05	0.00036	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—stomach cancer	7.4e-05	0.00036	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—stomach cancer	7.35e-05	0.000357	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—stomach cancer	7.32e-05	0.000356	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	7.18e-05	0.000349	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—stomach cancer	7.17e-05	0.000349	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—stomach cancer	7.14e-05	0.000347	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—stomach cancer	7.11e-05	0.000346	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—stomach cancer	7.11e-05	0.000346	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—stomach cancer	7.11e-05	0.000346	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—stomach cancer	7.11e-05	0.000346	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—stomach cancer	7.08e-05	0.000344	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—stomach cancer	6.89e-05	0.000335	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—stomach cancer	6.86e-05	0.000333	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—stomach cancer	6.8e-05	0.000331	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—stomach cancer	6.8e-05	0.00033	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—stomach cancer	6.62e-05	0.000322	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—stomach cancer	6.61e-05	0.000321	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—stomach cancer	6.58e-05	0.00032	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—stomach cancer	6.58e-05	0.00032	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—stomach cancer	6.57e-05	0.00032	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—stomach cancer	6.45e-05	0.000314	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—stomach cancer	6.36e-05	0.000309	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—stomach cancer	6.35e-05	0.000309	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—stomach cancer	6.15e-05	0.000299	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—stomach cancer	6.13e-05	0.000298	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—stomach cancer	6.11e-05	0.000297	CcSEcCtD
Bisoprolol—Rash—Methotrexate—stomach cancer	6.06e-05	0.000294	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—stomach cancer	6.05e-05	0.000294	CcSEcCtD
Bisoprolol—Headache—Methotrexate—stomach cancer	6.02e-05	0.000293	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—stomach cancer	5.97e-05	0.00029	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—stomach cancer	5.95e-05	0.000289	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—stomach cancer	5.89e-05	0.000286	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—stomach cancer	5.72e-05	0.000278	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—stomach cancer	5.71e-05	0.000277	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—stomach cancer	5.69e-05	0.000277	CcSEcCtD
Bisoprolol—Rash—Epirubicin—stomach cancer	5.67e-05	0.000276	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—stomach cancer	5.66e-05	0.000275	CcSEcCtD
Bisoprolol—Headache—Epirubicin—stomach cancer	5.63e-05	0.000274	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—stomach cancer	5.5e-05	0.000267	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—stomach cancer	5.34e-05	0.00026	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—stomach cancer	5.29e-05	0.000257	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—stomach cancer	5.25e-05	0.000255	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—stomach cancer	5.24e-05	0.000255	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—stomach cancer	5.21e-05	0.000253	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—stomach cancer	4.94e-05	0.00024	CcSEcCtD
Bisoprolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	5.88e-06	0.00122	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	5.83e-06	0.00121	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	5.82e-06	0.00121	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	5.79e-06	0.0012	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	5.66e-06	0.00118	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	5.65e-06	0.00117	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	5.59e-06	0.00116	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTP1—stomach cancer	5.58e-06	0.00116	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NDUFV1—stomach cancer	5.56e-06	0.00115	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NDUFS1—stomach cancer	5.56e-06	0.00115	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	5.52e-06	0.00115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	5.5e-06	0.00114	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	5.47e-06	0.00114	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	5.45e-06	0.00113	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	5.45e-06	0.00113	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.42e-06	0.00113	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	5.33e-06	0.00111	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	5.33e-06	0.00111	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.3e-06	0.0011	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	5.3e-06	0.0011	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTM1—stomach cancer	5.13e-06	0.00106	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.06e-06	0.00105	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PGLS—stomach cancer	4.96e-06	0.00103	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—BLVRB—stomach cancer	4.96e-06	0.00103	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FST—stomach cancer	4.86e-06	0.00101	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	4.83e-06	0.001	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ACAD8—stomach cancer	4.8e-06	0.000996	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	4.75e-06	0.000987	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FST—stomach cancer	4.75e-06	0.000987	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPAP2A—stomach cancer	4.73e-06	0.000981	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GAST—stomach cancer	4.69e-06	0.000973	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	4.69e-06	0.000973	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	4.65e-06	0.000965	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	4.59e-06	0.000952	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GAST—stomach cancer	4.59e-06	0.000952	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGG—stomach cancer	4.44e-06	0.000922	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	4.39e-06	0.000911	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGG—stomach cancer	4.35e-06	0.000902	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	4.3e-06	0.000892	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	4.28e-06	0.000888	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GMPR2—stomach cancer	4.28e-06	0.000888	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CA1—stomach cancer	4.21e-06	0.000875	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CKB—stomach cancer	4.21e-06	0.000875	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—FBP1—stomach cancer	4.21e-06	0.000875	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NDUFA2—stomach cancer	4.21e-06	0.000875	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	4.21e-06	0.000873	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	4.19e-06	0.000869	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	4.13e-06	0.000858	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	4.13e-06	0.000857	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	4.04e-06	0.000839	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	4.04e-06	0.000838	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLIN2—stomach cancer	3.96e-06	0.000822	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.91e-06	0.000812	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—IDH3B—stomach cancer	3.91e-06	0.000812	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CA2—stomach cancer	3.86e-06	0.0008	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NT5E—stomach cancer	3.76e-06	0.00078	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PGAM1—stomach cancer	3.76e-06	0.00078	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.64e-06	0.000755	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.64e-06	0.000755	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	3.58e-06	0.000744	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLCE1—stomach cancer	3.58e-06	0.000744	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	3.55e-06	0.000737	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	3.55e-06	0.000737	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	3.51e-06	0.000729	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—F2R—stomach cancer	3.51e-06	0.000729	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	3.48e-06	0.000721	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	3.48e-06	0.000721	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	3.46e-06	0.000717	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—F2R—stomach cancer	3.44e-06	0.000713	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	3.44e-06	0.000713	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—UMPS—stomach cancer	3.44e-06	0.000713	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	3.42e-06	0.00071	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	3.38e-06	0.000702	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	3.35e-06	0.000694	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	3.31e-06	0.000687	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	3.3e-06	0.000686	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PGLS—stomach cancer	3.24e-06	0.000673	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—BLVRB—stomach cancer	3.24e-06	0.000673	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	3.24e-06	0.000672	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	3.23e-06	0.000671	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PDHA1—stomach cancer	3.19e-06	0.000663	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ECHS1—stomach cancer	3.19e-06	0.000663	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	3.13e-06	0.00065	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.09e-06	0.000642	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	3.06e-06	0.000634	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	3.01e-06	0.000624	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TYMP—stomach cancer	3e-06	0.000623	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—FADS1—stomach cancer	3e-06	0.000623	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	3e-06	0.000622	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	2.99e-06	0.000621	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	2.94e-06	0.000611	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	2.93e-06	0.000608	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SREBF2—stomach cancer	2.81e-06	0.000584	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	2.81e-06	0.000583	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—RORA—stomach cancer	2.78e-06	0.000577	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CKB—stomach cancer	2.76e-06	0.000572	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CA1—stomach cancer	2.76e-06	0.000572	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FBP1—stomach cancer	2.76e-06	0.000572	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.76e-06	0.000572	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	2.75e-06	0.00057	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	2.67e-06	0.000555	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	2.66e-06	0.000552	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	2.61e-06	0.000543	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDOB—stomach cancer	2.6e-06	0.00054	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	2.6e-06	0.00054	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	2.59e-06	0.000538	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLIN2—stomach cancer	2.59e-06	0.000538	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	2.54e-06	0.000527	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CA2—stomach cancer	2.52e-06	0.000523	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	2.48e-06	0.000516	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PGAM1—stomach cancer	2.46e-06	0.00051	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NT5E—stomach cancer	2.46e-06	0.00051	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALOX5—stomach cancer	2.42e-06	0.000502	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	2.41e-06	0.000501	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—DPYD—stomach cancer	2.38e-06	0.000494	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	2.36e-06	0.00049	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	2.36e-06	0.00049	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLCE1—stomach cancer	2.34e-06	0.000486	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.34e-06	0.000486	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	2.33e-06	0.000484	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	2.31e-06	0.000479	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	2.28e-06	0.000474	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—UMPS—stomach cancer	2.25e-06	0.000466	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FYN—stomach cancer	2.24e-06	0.000465	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FYN—stomach cancer	2.19e-06	0.000455	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	2.12e-06	0.00044	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTT1—stomach cancer	2.11e-06	0.000437	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	2.1e-06	0.000436	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PDHA1—stomach cancer	2.09e-06	0.000433	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ECHS1—stomach cancer	2.09e-06	0.000433	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	2.08e-06	0.000432	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	2.07e-06	0.00043	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	2.06e-06	0.000427	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.03e-06	0.00042	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ENO1—stomach cancer	1.97e-06	0.00041	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FADS1—stomach cancer	1.96e-06	0.000408	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TYMP—stomach cancer	1.96e-06	0.000408	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	1.93e-06	0.0004	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	1.88e-06	0.000391	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	1.87e-06	0.000387	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	1.86e-06	0.000387	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SREBF2—stomach cancer	1.84e-06	0.000382	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	1.83e-06	0.000379	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	1.82e-06	0.000378	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—RORA—stomach cancer	1.82e-06	0.000377	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	1.78e-06	0.000369	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	1.77e-06	0.000367	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CD44—stomach cancer	1.75e-06	0.000363	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	1.74e-06	0.000361	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	1.73e-06	0.000359	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDOB—stomach cancer	1.7e-06	0.000353	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APC—stomach cancer	1.7e-06	0.000353	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APC—stomach cancer	1.66e-06	0.000345	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	1.63e-06	0.000338	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	1.59e-06	0.000331	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALOX5—stomach cancer	1.58e-06	0.000328	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	1.58e-06	0.000328	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—DPYD—stomach cancer	1.56e-06	0.000323	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	1.55e-06	0.000322	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	1.55e-06	0.000321	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	1.54e-06	0.000321	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	1.52e-06	0.000315	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	1.52e-06	0.000314	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.49e-06	0.000309	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	1.48e-06	0.000307	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	1.48e-06	0.000307	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	1.46e-06	0.000304	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTP1—stomach cancer	1.46e-06	0.000303	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	1.45e-06	0.000301	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	1.45e-06	0.0003	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—stomach cancer	1.44e-06	0.000299	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	1.43e-06	0.000297	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	1.43e-06	0.000296	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	1.41e-06	0.000293	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	1.39e-06	0.00029	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	1.38e-06	0.000287	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTT1—stomach cancer	1.38e-06	0.000286	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.36e-06	0.000282	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TYMS—stomach cancer	1.36e-06	0.000282	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	1.34e-06	0.000279	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—stomach cancer	1.34e-06	0.000278	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.32e-06	0.000275	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	1.32e-06	0.000274	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	1.32e-06	0.000273	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	1.29e-06	0.000268	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ENO1—stomach cancer	1.29e-06	0.000268	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ERCC2—stomach cancer	1.26e-06	0.000262	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	1.25e-06	0.00026	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	1.24e-06	0.000258	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	1.22e-06	0.000254	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	1.22e-06	0.000254	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	1.22e-06	0.000253	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	1.2e-06	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	1.19e-06	0.000247	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—stomach cancer	1.19e-06	0.000246	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	1.17e-06	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	1.16e-06	0.000242	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—JUN—stomach cancer	1.16e-06	0.000242	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CD44—stomach cancer	1.14e-06	0.000237	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	1.14e-06	0.000237	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—JUN—stomach cancer	1.14e-06	0.000236	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	1.13e-06	0.000235	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	1.13e-06	0.000234	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	1.11e-06	0.00023	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	1.1e-06	0.000229	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	1.1e-06	0.000229	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAV1—stomach cancer	1.09e-06	0.000227	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA1—stomach cancer	1.09e-06	0.000226	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	1.08e-06	0.000224	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	1.02e-06	0.000211	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	1.01e-06	0.000209	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	9.95e-07	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	9.85e-07	0.000204	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	9.73e-07	0.000202	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	9.62e-07	0.0002	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—stomach cancer	9.61e-07	0.0002	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTP1—stomach cancer	9.54e-07	0.000198	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—stomach cancer	9.41e-07	0.000195	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	9.41e-07	0.000195	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MYC—stomach cancer	9.36e-07	0.000194	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	9.15e-07	0.00019	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MYC—stomach cancer	9.15e-07	0.00019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	9.15e-07	0.00019	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	8.95e-07	0.000186	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	8.95e-07	0.000186	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TYMS—stomach cancer	8.87e-07	0.000184	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—stomach cancer	8.77e-07	0.000182	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	8.64e-07	0.000179	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—stomach cancer	8.64e-07	0.000179	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	8.46e-07	0.000175	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NOS3—stomach cancer	8.27e-07	0.000172	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ERCC2—stomach cancer	8.25e-07	0.000171	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	7.94e-07	0.000165	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	7.77e-07	0.000161	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—stomach cancer	7.75e-07	0.000161	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TP53—stomach cancer	7.68e-07	0.000159	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—stomach cancer	7.56e-07	0.000157	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TP53—stomach cancer	7.52e-07	0.000156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	7.35e-07	0.000152	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	7.19e-07	0.000149	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAV1—stomach cancer	7.15e-07	0.000148	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA1—stomach cancer	7.13e-07	0.000148	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—stomach cancer	7.03e-07	0.000146	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—stomach cancer	6.88e-07	0.000143	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—stomach cancer	6.29e-07	0.00013	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—stomach cancer	5.65e-07	0.000117	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NOS3—stomach cancer	5.41e-07	0.000112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—stomach cancer	4.94e-07	0.000103	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	4.65e-07	9.66e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.04e-07	6.31e-05	CbGpPWpGaD
